We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 16,917

On Alternative Design, Take Two Negligence
  • Reed Smith LLP
  • USA
  • February 27 2017

Back in 2013, inspired by a win of our own that we were actually allowed to blog about, we put up a post entitled “On Alternative Design.” Taking the


Porzio Life Sciences 2016 Year-End Report: The Ever Changing World of Life Sciences
  • Porzio Bromberg & Newman PC
  • USA
  • February 27 2017

We at Porzio Life Sciences (“PorzioLS”) have been a leading resource for the life sciences industry for over 12 years. As such, we have been front and


President Executive Order - Consumer Product Safety Commission Response to Regulatory Overhaul
  • Squire Patton Boggs
  • USA
  • February 27 2017

In response to President Trump's Executive Order requiring government agencies to repeal two regulations for each new one issued, the head of the


Industry groups say final rule on intended use establishes unfounded legal standard, call for indefinite stay
  • Loeb & Loeb LLP
  • USA
  • February 27 2017

Citing violations of the APA and what they call the establishment of a "new and unjustified legal standard," a coalition of industry groups is


A Challenge to Hague Service by Mail Is Now Before the SCOTUSFinally
  • Wilson Elser
  • USA
  • February 27 2017

In Water Splash v. Menon, case number 16-254 before the U.S. Supreme Court, a long-standing and deep split of authority on a basic question involving


FDA issues warning letter to Fresenius subsidiary over misleading promotional material
  • Loeb & Loeb LLP
  • USA
  • February 27 2017

For the second time, the FDA warned Fenwal about misleading promotional material for InterSol that omits risk information. The agency raises concerns


FDA’s enforcement stats paint opposing pictures for pharmaceuticals, medical devices
  • Loeb & Loeb LLP
  • USA
  • February 27 2017

The agency's annual enforcement report signals mixed enforcement trends for pharmaceutical companies and medical device makers. While the


Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • Global, USA
  • February 24 2017

A structured guide to product regulation and liability in the USA


NAD shoots down Bowflex’s claims of dramatic weight loss as unsupported; disclaimer not enough
  • Porter Wright Morris & Arthur LLP
  • USA
  • February 24 2017

Nautilus’s Bowflex TreadClimber just became the latest example of enforcement action against a health and fitness product by the National Advertising


CIT rules on Made in USA claim
  • Kelley Drye & Warren LLP
  • USA
  • February 24 2017

A recent ruling by the U.S. Court of International Trade (CIT) has important implications for importers and manufacturers making “Made in USA” claims